Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some extracts from the Cohen Report

gcduck

You bring up some very good questions. Why would Cohen issue price targets for 2011 when it is Jan.of 2009? Is there not "something" positive we can look forward to between now and then? Something happened in the J3 case that took the shine off future licenses, what was it? Blunist now has the rose colored glasses on. Why can't these bb stocks be straight with their shareholders?

IMO



Share
New Message
Please login to post a reply